Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia.

Thrombosis and haemostasis - 1 Jan 2015

Lee Yun-Gyoo, Kim Inho, Kwon Ji-hyun, Yoon Sung Soo, Park Seongyang, Song Leo, Yoon Jae-Ho, Shin Seung-Hwan, Min Woo-Sung, Kim Hee-Je

Abstract excerpt

Due to the high risk of thrombocytopenia and haemorrhage, thrombotic complications have received little attention in patients with acute myeloid leukemia (AML). Furthermore, the predictive role of cytogenetics on venous thromboembolism (VTE) has largely been ignored. This study aimed to evaluate the incidence, risk factors, and prognostic aspects of VTE in AML. A total of 811 consecutive patients with AML were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytogenetic Analysis
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Predictive Value of Tests

Share to Propensity Score

Share to Proportional Hazards Models

Share to Republic of Korea

Share to Venous Thromboembolism

Source

Identifiers

PMID: 25339605
DOI: 10.1160/TH13-12-1020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia.PMID 25339605Read ↗

The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.Semantic proximity Read ↗

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.Semantic proximity Read ↗

MicroRNAs as prognostic biomarkers for (cancer–associated) venous thromboembolismSemantic proximity Read ↗

A review of the venous thrombotic issues associated with multiple myeloma.Semantic proximity Read ↗

Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.Semantic proximity Read ↗

Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.Semantic proximity Read ↗

Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.Semantic proximity Read ↗

Analysis of early death in newly diagnosed acute promyelocytic leukemia patientsSemantic proximity Read ↗

Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens.Semantic proximity Read ↗

Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide.Semantic proximity Read ↗

Immune Checkpoint Inhibitors and Car-T Cell Therapy: Thrombotic and Vascular ComplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.